Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. (Q53873539)
Jump to navigation
Jump to search
scientific article published in May 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. |
scientific article published in May 2002 |
Statements
Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. (English)
1 reference
James G Krueger
1 reference
Alice B Gottlieb
1 reference
Knut Wittkowski
1 reference
Russell Dedrick
1 reference
Patricia Ann Walicke
1 reference
Marvin Garovoy
1 reference
1 May 2002
1 reference
138
1 reference
5
1 reference
591-600
1 reference
Identifiers
1 reference